G-protein β3 subunit gene variant and left ventricular hypertrophy in essential hypertension

Hypertension

Volumn 35, Issue 1 II, 2000, Pages 214-218

  Poch, Esteban ^a   González, Daniel ^a   Gómez Angelats, Elisenda ^a   Enjuto, Montserrat ^a   Paré, Joan Carles ^a   Rivera, Francisca ^a   De La Sierra, Alejandro ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

G proteins; Genes; Hypertension, essential; Hypertrophy; Polymorphism

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0342514751     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.35.1.214     Document Type: Conference Paper

References (31)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
2. Drayer JIM, Weber MA, DeYoung JL. BP as a determinant of cardiac left ventricular muscle mass. Arch Intern Med. 1983;143:90-92.
3. Devereux RB, Roman MJ. Hypertensive cardiac hypertrophy: pathophysiologic and clinical characteristics. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press Ltd; 1995:409-432.
4. Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors: the Framingham Heart Study. Ann Intern Med. 1988;108:7-13.
5. Verhaaren HA, Schieken RM, Mosteller M, Hewitt JK, Eaves LJ, Nance WE. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia twin study). Am J Cardiol. 1991;68:661-668.
6. Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension. 1997; 30:1025-1028.
7. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann H-E, Jakobs KH, Horsthenke B. Association of a human G-protein β3 subunit variant with hypertension. Nat Genet. 1998;18:45-48.
8. Siffert W, Düsing R. Sodium-proton exchange and primary hypertension: an update. Hypertension. 1995;26:649-655.
9. + exchange and growth factor-induced cytosolic pH changes: role in cellular proliferation. Biochim Biophys Acta. 1989;988:73-97.
10. Rosskopf D, Frömter E, Siffert W. Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients. J Clin Invest. 1993;92:2553-2559.
11. Siffert W, Rosskopf D, Moritz A, Wieland T, Kaldenberg-Stasch S, Kettler N, Nartung K, Beckmann S. Jakobs KH. Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. J Clin Invest. 1995;96:759-766.
12. Schunkert H, Hense HW, Döring A, Riegger GAJ, Siffert W. Association between a polymorphism in the G-protein β3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension. 1998; 32:510-513.
13. Hegele RA, Harris SB, Hanley AJG, Cao H, Zinman B. G protein β3 subunit gene variant and blood pressure variation in Canadian Oji-Cree. Hypertension. 1998;32:688-692.
14. Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y. G protein β3 subunit variant and essential hypertension in Japanese. Hypertension. 1998;32:935-938.
15. Beige J, Hohenbleicher H, Distler A, Sharma AM. G-protein β3 subunit C825T variant and ambulatory blood pressure in essential hypertension. Hypertension. 1999;33:1049-1051.
16. De la Sierra A, Coca A, Paré JC, Sánchez M, Valls V, Urbano-Márquez A. Erythrocyte ion fluxes in essential hypertensive patients with left ventricular hypertrophy. Circulation. 1993;88:1628-1633.
17. Sahn DJ, De Maria A, Kisslo J, Weyman A. The Committee on M-mode standardization of the American Society: recommendations regarding quantitation in M-mode echocardiography. Circulation. 1978;58: 1071-1083.
18. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613-618.
19. Devereux RB, Casale PN, Kligfield P, Eisenberg RR, Miller D, Campo E, Alonso DR. Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am J Cardiol. 1986;57: 1388-1393.
20. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345-352.
21. Canessa M, Falkner B, Hulman S. Red blood cell sodium-proton exchange in hypertensive blacks with insulin-resistant glucose disposal. Hypertension. 1993;22:204-213.
22. + retention in patients with essential hypertension. Am J Hypertens. 1995;8:124-132.
23. + antiporter as a candidate gene in human essential hypertension. Hypertension. 1991;17:8-14.
24. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. 2nd ed. New York. NY: Raven Press Ltd; 1994:67-88.
25. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265:2037-2048.
26. Hansen HS, Nielsen JR. Hyldebrandt N, Froberg K. Blood pressure and cardiac structure in children with a parental history of hypertension: the Odense Schoolchild Study. J Hypertens. 1992;10:677-682.
27. Schunkert H, Hense H, Holmer S, Slender M, Perz S, Keil U, Lorell BH, Riegger GAJ. Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-1638.
28. Lindpaintner K, Lee M, Larson MG, Rao VS, Pfeffer MA, Ordovas JM, Schaefer EJ, Wilson AF, Wilson PWF, Vasan RS, Myers RH, Levy D. Absence of association of genetic linkage between the angiotensinconverting enzyme gene and left ventricular mass. N Engl J Med. 1996; 334:1023-1028.
29. Gaul G, Gierschik P, Marme D. Pertussis toxin inhibits angiotensin II-mediated phosphatidylinositol breakdown and ADP-ribosylates a 40 Kd protein in cultured smooth muscle cells. Biochem Biophys Res Commun. 1988;150:841-847.
30. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977-984.
31. Rosenberg ME, Smith LJ, Correa-Rotter R, Hosteller TH. The paradox of the renin angiotensin system in chronic renal disease. Kidney Int. 1994; 45:403-410.